Thomas Kronbach

3.1k total citations · 2 hit papers
37 papers, 2.6k citations indexed

About

Thomas Kronbach is a scholar working on Pharmacology, Molecular Biology and Oncology. According to data from OpenAlex, Thomas Kronbach has authored 37 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pharmacology, 16 papers in Molecular Biology and 11 papers in Oncology. Recurrent topics in Thomas Kronbach's work include Pharmacogenetics and Drug Metabolism (21 papers), Drug Transport and Resistance Mechanisms (8 papers) and Phosphodiesterase function and regulation (7 papers). Thomas Kronbach is often cited by papers focused on Pharmacogenetics and Drug Metabolism (21 papers), Drug Transport and Resistance Mechanisms (8 papers) and Phosphodiesterase function and regulation (7 papers). Thomas Kronbach collaborates with scholars based in Switzerland, Germany and United States. Thomas Kronbach's co-authors include Urs Meyer, Volker Fischer, Frank J. Gonzalez, Pierre Dayer, J. Gut, Josef Gut, U. Thomas Meier, Eric F. Johnson, Michel Eichelbaum and Eric F. Johnson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Biochemistry.

In The Last Decade

Thomas Kronbach

37 papers receiving 2.4k citations

Hit Papers

Oxidation of midazolam an... 1988 2026 2000 2013 1989 1988 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Oxidation of midazolam and triazolam by human liver cytochrome P450IIIA4.
    1989 481 citations Thomas Kronbach, Urs Meyer et al. Molecular Pharmacology profile →
  2. Cyclosporine metabolism in human liver: Identification of a cytochrome P-450III gene family as the major cyclosporine-metabolizing enzyme explains interactions of cyclosporine with other drugs
    1988 465 citations Thomas Kronbach, Volker Fischer et al. Clinical Pharmacology & Therapeutics profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Thomas Kronbach 1.6k 929 677 421 379 37 2.6k
Mark VandenBranden 2.4k 1.5× 1.3k 1.4× 615 0.9× 492 1.2× 361 1.0× 28 3.1k
Yukiharu Inui 2.4k 1.5× 1.3k 1.4× 956 1.4× 361 0.9× 377 1.0× 20 3.9k
Su Duan 1.6k 1.0× 761 0.8× 534 0.8× 531 1.3× 458 1.2× 43 2.9k
S. Ball 1.5k 1.0× 745 0.8× 599 0.9× 256 0.6× 295 0.8× 28 2.3k
Robert L. Haining 1.7k 1.0× 856 0.9× 410 0.6× 282 0.7× 401 1.1× 28 2.3k
Barbara J. Ring 2.7k 1.7× 1.5k 1.6× 1.0k 1.5× 513 1.2× 641 1.7× 59 4.7k
Jin‐ding Huang 1.0k 0.6× 779 0.8× 468 0.7× 351 0.8× 210 0.6× 61 1.9k
Toshiro Niwa 1.1k 0.7× 505 0.5× 452 0.7× 220 0.5× 258 0.7× 98 2.2k
Mitchell A. Hamman 1.3k 0.8× 734 0.8× 256 0.4× 388 0.9× 341 0.9× 22 2.0k
Lydiane Pichard 1.3k 0.8× 808 0.9× 450 0.7× 323 0.8× 191 0.5× 33 2.2k

Countries citing papers authored by Thomas Kronbach

Since Specialization
Citations

This map shows the geographic impact of Thomas Kronbach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Kronbach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Kronbach more than expected).

Fields of papers citing papers by Thomas Kronbach

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Kronbach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Kronbach. The network helps show where Thomas Kronbach may publish in the future.

Co-authorship network of co-authors of Thomas Kronbach

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Kronbach. A scholar is included among the top collaborators of Thomas Kronbach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Kronbach. Thomas Kronbach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Richter, Wito, Thomas Hermsdorf, Thomas Kronbach, & D Dettmer. (2002). Refolding and Purification of Recombinant Human PDE7A Expressed in Escherichia coli as Inclusion Bodies. Protein Expression and Purification. 25(1). 138–148. 11 indexed citations
3.
Egerland, Ute, et al.. (2002). AWD 12-281. Drugs of the Future. 27(2). 111–111. 5 indexed citations
4.
Olbrich, Martin, et al.. (2001). Morpholine ring oxidation of AWD 131-138, a novel anxiolytic and anticonvulsant, is catalysed by CYP1A1/2.. Drug Metabolism Reviews. 33. 89. 2 indexed citations
5.
Richter, Wito, et al.. (2001). Identification of inhibitor binding sites of the cAMP-specific phosphodiesterase 4. Cellular Signalling. 13(4). 287–297. 19 indexed citations
6.
Richter, Wito, et al.. (2001). Identification of substrate specificity determinants in human cAMP-specific phosphodiesterase 4A by single-point mutagenesis. Cellular Signalling. 13(3). 159–167. 12 indexed citations
7.
Peter, G., et al.. (2001). New metabolic pathways of alpha-lipoic acid.. PubMed. 29(6). 855–62. 63 indexed citations
8.
Richter, Wito, Thomas Hermsdorf, Hauke Lilie, et al.. (2000). Refolding, Purification, and Characterization of Human Recombinant PDE4A Constructs Expressed in Escherichia coli. Protein Expression and Purification. 19(3). 375–383. 12 indexed citations
9.
Peter, G., et al.. (2000). Disposition and Metabolism of Cetrorelix, A Potent Luteinizing Hormone-Releasing Hormone Antagonist, in Rats and Dogs1. Drug Metabolism and Disposition. 28(1). 10–20. 14 indexed citations
10.
Grunwald, Christian, et al.. (1999). Metabolism of Retigabine (D-23129), a Novel Anticonvulsant. Drug Metabolism and Disposition. 27(5). 613–622. 77 indexed citations
11.
Rostock, A, C. Tober, Rita Dost, et al.. (1998). AWD-131-138. Drugs of the Future. 23(3). 253–253. 18 indexed citations
12.
Richardson, Toby H., Mei‐Hui Hsu, Thomas Kronbach, et al.. (1993). Purification and Characterization of Recombinant-Expressed Cytochrome P450 2C3 from Escherichia coli: 2C3 Encodes the 6β-Hydroxylase Deficient Form of P450-3b. Archives of Biochemistry and Biophysics. 300(1). 510–516. 40 indexed citations
13.
Kronbach, Thomas. (1991). [49] Bufuralol, dextromethorphan, and debrisoquine as prototype substrates for human P450IID6. Methods in enzymology on CD-ROM/Methods in enzymology. 206. 509–517. 52 indexed citations
14.
Lawton, Michael, Thomas Kronbach, Eric F. Johnson, & R.M. Philpot. (1991). Properties of Expressed and Native Flavin-Containing Monooxygenases: Evidence of Multiple Forms in Rabbit Liver and Lung. Molecular Pharmacology. 40(5). 692–698. 26 indexed citations
15.
Kronbach, Thomas, Byron Kemper, & Eric F. Johnson. (1991). A hypervariable region of P450IIC5 confers progesterone 21-hydroxylase activity to P450IIC1. Biochemistry. 30(25). 6097–6102. 42 indexed citations
16.
Kroemer, Heyo K., Gerd Mikus, Thomas Kronbach, Urs Meyer, & Michel Eichelbaum. (1989). In vitro characterization of the human cytochrome P-450 involved in polymorphic oxidation of propafenone. Clinical Pharmacology & Therapeutics. 45(1). 28–33. 71 indexed citations
17.
Kronbach, Thomas, Volker Fischer, & Urs Meyer. (1988). Cyclosporine metabolism in human liver: Identification of a cytochrome P-450III gene family as the major cyclosporine-metabolizing enzyme explains interactions of cyclosporine with other drugs. Clinical Pharmacology & Therapeutics. 43(6). 630–635. 465 indexed citations breakdown →
18.
Dayer, Pierre, et al.. (1987). Enzymatic basis of the debrisoquine/sparteine-type genetic polymorphism of drug oxidation. Biochemical Pharmacology. 36(23). 4145–4152. 56 indexed citations
19.
20.
Voelter, Wolfgang, Thomas Kronbach, Karl Zech, & Reinhard Huber. (1982). A simple high-performance liquid chromatographic pre-column technique for investigation of drug metabolism in biological fluids. Journal of Chromatography A. 239. 475–482. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mark VandenBranden Breakdown of academic impact, for papers by Yukiharu Inui Breakdown of academic impact, for papers by Su Duan Breakdown of academic impact, for papers by S. Ball Breakdown of academic impact, for papers by Robert L. Haining Breakdown of academic impact, for papers by Barbara J. Ring Breakdown of academic impact, for papers by Jin‐ding Huang Breakdown of academic impact, for papers by Toshiro Niwa Breakdown of academic impact, for papers by Mitchell A. Hamman Breakdown of academic impact, for papers by Lydiane Pichard
Rankless by CCL
2026